ACVAX Fees and Costs — Strategic Allocation: Aggressive Fund, A Class
Data updated: 2026-10-14
The net expense ratio is 1.04% (1.58% before fee waivers). This share class carries a maximum front-end sales load of 5.75%. In fiscal 2026 the fund paid $146K in broker commissions, 0.0201% of average net assets, and portfolio turnover was 60%.
ACVAX Fees and Expenses
Annual operating expenses and sales charges of ACVAX. Prospectus, as of December 1, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 1.15% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.01% |
| Gross expense ratio | 1.58% |
| Fee waiver | −0.54% |
| Net expense ratio | 1.04% |
| Sales charges | |
|---|---|
| Max front load | 5.75% |
| Max deferred load | 0.00% |
| Redemption fee | — |
ACVAX Costs Over Time
On $10,000 invested in ACVAX, assuming 5% a year before costs, total costs come to $1,358 over 5 years, cutting the return by 2.34% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $575 | $575 | $575 |
| Fund expenses (net expense ratio 1.04%) | $103 | $321 | $556 |
| Trading costs (broker commissions) | $2 | $6 | $11 |
| Lost growth on money paid in costs | $29 | $107 | $216 |
| Total costs | $709 | $1,009 | $1,358 |
| Value after costs | $9,791 | $10,567 | $11,405 |
| Impact on return, per year | 7.09% | 3.14% | 2.34% |
ACVAX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending July 31, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0201%
- Total broker commissions: $146K
- Bought from dealers (principal trades, not a cost): $859.1M
- Portfolio turnover (prospectus): 60%
ACVAX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| BANK OF AMERICA MERRILL LYNCH | $16K | 16.56% |
| CITIGROUP CAPITAL MARKETS INC. | $12K | 12.42% |
| CITADEL SECURITIES CSHC US LLC | $11K | 11.74% |
| J.P. MORGAN SECURITIES | $11K | 11.32% |
| MORGAN STANLEY | $10K | 10.47% |
| JANE STREET GROUP LLC | $10K | 10.28% |
| UBS WARBURG | $7K | 7.49% |
| BERNSTEIN INSTITUTIONAL SERVICES | $7K | 7.05% |
| JEFFERIES LLC | $7K | 6.99% |
| BARCLAYS CAPITAL | $6K | 5.68% |
ACVAX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| J.P. MORGAN SECURITIES | $163.9M | 21.29% |
| MORGAN STANLEY | $127.2M | 16.52% |
| CITIGROUP CAPITAL MARKETS INC. | $120.7M | 15.68% |
| BARCLAYS CAPITAL | $111.4M | 14.47% |
| BANK OF AMERICA MERRILL LYNCH | $79.6M | 10.34% |
| GOLDMAN SACHS | $73.9M | 9.60% |
| UBS WARBURG | $47.7M | 6.20% |
| RBC CAPITAL MARKETS | $16.4M | 2.12% |
| SMBC NIKKO SECURITIES AMERICA INC. | $14.9M | 1.93% |
| BMO CAPITAL MARKETS | $14.2M | 1.84% |
Strategic Allocation: Aggressive Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| AAAUX | R6 Class | 0.44% | none |
| AAAIX | I Class | 0.59% | none |
| ASAUX | R5 Class | 0.59% | none |
| TWSAX | Investor Class | 0.79% | none |
| ACVAX | A Class | 1.04% | 5.75% |
| AAARX | R Class | 1.29% | none |
| ASTAX | C Class | 1.79% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.